Concepedia

Abdomino-pelvic hypertherma and intraperitoneal carboplatin in epithelial ovarian cancer: Feasibility, tolerance and pharmacology

Silvia C. Formenti, Prakash N. Shrivastava, Michael D. Sapozink, Gabor Jozsef, Kenneth K. Chan, Susan Jeffers, Paul C. Morrow, Franco M. Muggia

International Journal of Radiation Oncology*Biology*Physics · 1996 · 20 citations · 27 references

DOI

Concepts

References

27

Carboplatin dosage: prospective evaluation of a simple formula based on renal function.

A. Hilary Calvert, David R. Newell, Lindsey Gumbrell et al. · Journal of Clinical Oncology · 1989 · 1.9K citations

, , +17

Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer.

Dedrick Rl, Myers Ce, Bungay Pm et al. · PubMed · 1978 · 743 citations

, , +17

Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria

Stephanie Green, Geoffrey R. Weiss · Investigational New Drugs · 1992 · 616 citations

, , +14

Long-term survival of advanced refractory ovarian carcinoma patients with small-volume disease treated with intraperitoneal chemotherapy.

Stephen B. Howell, Solomon Zimm, Maurie Markman et al. · Journal of Clinical Oncology · 1987 · 221 citations

, , +13

Intraperitoneal cis-diamminedichloroplatinum with systemic thiosulfate protection.

Stephen B. Howell, C E Pfeifle, Wally E. Wung et al. · PubMed · 1983 · 197 citations

, , +17